FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

30197011000001103: Naloxegol 12.5mg tablets (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Sep 2015. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
93880301000001115 Naloxegol 12.5mg tablets (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
93880401000001111 Naloxegol 12.5mg tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

1 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Naloxegol 12.5mg tablets Is a Naloxegol true Inferred relationship Existential restriction modifier
Naloxegol 12.5mg tablets Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Naloxegol 12.5mg tablets Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Naloxegol 12.5mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Naloxegol 12.5mg tablets Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Naloxegol 12.5mg tablets Is a Naloxegol false Inferred relationship Existential restriction modifier
Naloxegol 12.5mg tablets Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Naloxegol 12.5mg tablets Has specific active ingredient Naloxegol oxalate false Inferred relationship Existential restriction modifier
Naloxegol 12.5mg tablets VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Naloxegol 12.5mg tablets VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Naloxegol 12.5mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Naloxegol false Inferred relationship Existential restriction modifier
Naloxegol 12.5mg tablets Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Naloxegol 12.5mg tablets Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Naloxegol 12.5mg tablets Has specific active ingredient Naloxegol oxalate true Inferred relationship Existential restriction modifier
Naloxegol 12.5mg tablets Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Naloxegol true Inferred relationship Existential restriction modifier
Naloxegol 12.5mg tablets Has basis of strength substance Naloxegol false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Moventig 12.5mg tablets (AstraZeneca UK Ltd) Is a True Naloxegol 12.5mg tablets Inferred relationship Existential restriction modifier
Naloxegol 12.5mg tablets 30 tablet Has VMP True Naloxegol 12.5mg tablets Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start